Commit To Buy Intercept Pharmaceuticals At $150, Earn 23.7% Using Options

Investors considering a purchase of Intercept Pharmaceuticals Inc (ICPT) stock, but tentative about paying the going market price of $223.00/share, might benefit from considering selling puts among the alternative strategies at their disposal. One interesting put contract in particular, is the January 2016 put at the $150 strike, which has a bid at the time of this writing of $35.50..